J Park Dis 7:619628 Antonini A et al (2007) Duodenal levodopa infusion for advanced Parkinsons disease: 12-month treatment outcome
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss Laura Joszt, MA Rose McNulty Key Takeaways The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events
Craig: Yes, which will allow things like serotonin to work a little bit longer in that synaptic cleft
Formulation: Avoid synthetic fillers, artificial colors, and unnecessary additives
Results may vary for everyone, but most notice more energy, a faster metabolism, and less fat within just a few weeks
Probiotics are thought to exert beneficial effects through their ability to reshape the composition and function of GI microbial ecosystems positively (208)